691 related articles for article (PubMed ID: 25583385)
1. Early cellular immune response to a new candidate mycobacterial vaccine antigen in childhood tuberculosis.
Schepers K; Dirix V; Mouchet F; Verscheure V; Lecher S; Locht C; Mascart F
Vaccine; 2015 Feb; 33(8):1077-83. PubMed ID: 25583385
[TBL] [Abstract][Full Text] [Related]
2. Involvement of methylated HBHA expressed from Mycobacterium smegmatis in an IFN-γ release assay to aid discrimination between latent infection and active tuberculosis in BCG-vaccinated populations.
Wen HL; Li CL; Li G; Lu YH; Li HC; Li T; Zhao HM; Wu K; Lowrie DB; Lv JX; Lu SH; Fan XY
Eur J Clin Microbiol Infect Dis; 2017 Aug; 36(8):1415-1423. PubMed ID: 28429162
[TBL] [Abstract][Full Text] [Related]
3. Broad heparin-binding haemagglutinin-specific cytokine and chemokine response in infants following Mycobacterium bovis BCG vaccination.
Smith SG; Lecher S; Blitz R; Locht C; Dockrell HM
Eur J Immunol; 2012 Sep; 42(9):2511-22. PubMed ID: 22653733
[TBL] [Abstract][Full Text] [Related]
4. Enhanced effect of BCG vaccine against pulmonary Mycobacterium tuberculosis infection in mice with lung Th17 response to mycobacterial heparin-binding hemagglutinin adhesin antigen.
Fukui M; Shinjo K; Umemura M; Shigeno S; Harakuni T; Arakawa T; Matsuzaki G
Microbiol Immunol; 2015 Dec; 59(12):735-43. PubMed ID: 26577130
[TBL] [Abstract][Full Text] [Related]
5. Heparin-binding, hemagglutinin-specific IFN-gamma synthesis at the site of infection during active tuberculosis in humans.
Place S; Verscheure V; de San N; Hougardy JM; Schepers K; Dirix V; Dediste A; Michel O; Drowart A; Allard SD; Doherty TM; Lecher S; Locht C; Mascart F
Am J Respir Crit Care Med; 2010 Sep; 182(6):848-54. PubMed ID: 20508213
[TBL] [Abstract][Full Text] [Related]
6. Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection.
van Dissel JT; Soonawala D; Joosten SA; Prins C; Arend SM; Bang P; Tingskov PN; Lingnau K; Nouta J; Hoff ST; Rosenkrands I; Kromann I; Ottenhoff TH; Doherty TM; Andersen P
Vaccine; 2011 Mar; 29(11):2100-9. PubMed ID: 21256189
[TBL] [Abstract][Full Text] [Related]
7. Specific Host Signatures for the Detection of Tuberculosis Infection in Children in a Low TB Incidence Country.
Dreesman A; Corbière V; Libin M; Racapé J; Collart P; Singh M; Locht C; Mascart F; Dirix V
Front Immunol; 2021; 12():575519. PubMed ID: 33790886
[TBL] [Abstract][Full Text] [Related]
8. The candidate tuberculosis vaccine Mtb72F/AS02 in PPD positive adults: a randomized controlled phase I/II study.
Spertini F; Audran R; Lurati F; Ofori-Anyinam O; Zysset F; Vandepapelière P; Moris P; Demoitié MA; Mettens P; Vinals C; Vastiau I; Jongert E; Cohen J; Ballou WR
Tuberculosis (Edinb); 2013 Mar; 93(2):179-88. PubMed ID: 23219236
[TBL] [Abstract][Full Text] [Related]
9. Future Path Toward TB Vaccine Development: Boosting BCG or Re-educating by a New Subunit Vaccine.
Gupta N; Garg S; Vedi S; Kunimoto DY; Kumar R; Agrawal B
Front Immunol; 2018; 9():2371. PubMed ID: 30386336
[TBL] [Abstract][Full Text] [Related]
10. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
[TBL] [Abstract][Full Text] [Related]
11. Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice.
Stylianou E; Diogo GR; Pepponi I; van Dolleweerd C; Arias MA; Locht C; Rider CC; Sibley L; Cutting SM; Loxley A; Ma JK; Reljic R
Eur J Immunol; 2014 Feb; 44(2):440-9. PubMed ID: 24214530
[TBL] [Abstract][Full Text] [Related]
12. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status.
Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y
Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942
[TBL] [Abstract][Full Text] [Related]
13. Differential T cell responses against DosR-associated antigen Rv2028c in BCG-vaccinated populations with tuberculosis infection.
Zhao HM; Du R; Li CL; Ji P; Li HC; Wu K; Hu Z; Lu SH; Lowrie DB; Fan XY
J Infect; 2019 Apr; 78(4):275-280. PubMed ID: 30528871
[TBL] [Abstract][Full Text] [Related]
14. Characterization of CD4/CD8+ αβ and Vγ2Vδ2+ T cells in HIV-negative individuals with different Mycobacterium tuberculosis infection statuses.
Gao Y; Zhang S; Ou Q; Shen L; Wang S; Wu J; Weng X; Chen ZW; Zhang W; Shao L
Hum Immunol; 2015 Nov; 76(11):801-7. PubMed ID: 26429305
[TBL] [Abstract][Full Text] [Related]
15. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
16. HBHA-Induced Polycytotoxic CD4
Aerts L; Selis E; Corbière V; Smits K; Van Praet A; Dauby N; Petit E; Singh M; Locht C; Dirix V; Mascart F
J Immunol; 2019 Jan; 202(2):421-427. PubMed ID: 30559320
[TBL] [Abstract][Full Text] [Related]
17. Immuno-Diagnosis of Active Tuberculosis by a Combination of Cytokines/Chemokines Induced by Two Stage-Specific Mycobacterial Antigens: A Pilot Study in a Low TB Incidence Country.
Dirix V; Collart P; Van Praet A; Hites M; Dauby N; Allard S; Racapé J; Singh M; Locht C; Mascart F; Corbière V
Front Immunol; 2022; 13():842604. PubMed ID: 35359958
[TBL] [Abstract][Full Text] [Related]
18. Age-Stratified T Cell Responses in Children Infected with
Dreesman A; Corbière V; Dirix V; Smits K; Debulpaep S; De Schutter I; Libin M; Singh M; Malfroot A; Locht C; Mascart F
Front Immunol; 2017; 8():1059. PubMed ID: 28928738
[TBL] [Abstract][Full Text] [Related]
19. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
Wang QL; Pan Q; Ma Y; Wang K; Sun P; Liu S; Zhang XL
Vaccine; 2009 Nov; 27(48):6712-22. PubMed ID: 19733584
[TBL] [Abstract][Full Text] [Related]
20. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]